197 related articles for article (PubMed ID: 23235478)
1. Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.
Bouley R; Nunes P; Andriopoulos B; McLaughlin M; Webber MJ; Lin HY; Babitt JL; Gardella TJ; Ausiello DA; Brown D
Am J Physiol Renal Physiol; 2013 Mar; 304(5):F553-64. PubMed ID: 23235478
[TBL] [Abstract][Full Text] [Related]
2. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.
Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D
Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128
[TBL] [Abstract][Full Text] [Related]
3. Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.
Chen S; Webber MJ; Vilardaga JP; Khatri A; Brown D; Ausiello DA; Lin HY; Bouley R
Endocrinology; 2011 Oct; 152(10):3893-904. PubMed ID: 21828182
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.
Bouley R; Lin HY; Raychowdhury MK; Marshansky V; Brown D; Ausiello DA
Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1390-401. PubMed ID: 15677378
[TBL] [Abstract][Full Text] [Related]
5. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells.
Bouley R; Sun TX; Chenard M; McLaughlin M; McKee M; Lin HY; Brown D; Ausiello DA
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C750-62. PubMed ID: 12801889
[TBL] [Abstract][Full Text] [Related]
6. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.
Yi X; Bouley R; Lin HY; Bechoua S; Sun TX; Del Re E; Shioda T; Raychowdhury MK; Lu HA; Abou-Samra AB; Brown D; Ausiello DA
Am J Physiol Renal Physiol; 2007 May; 292(5):F1303-13. PubMed ID: 17287200
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells.
Raychowdhury MK; Ramos AJ; Zhang P; McLaughin M; Dai XQ; Chen XZ; Montalbetti N; Del Rocío Cantero M; Ausiello DA; Cantiello HF
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F87-97. PubMed ID: 18945824
[TBL] [Abstract][Full Text] [Related]
8. Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.
Zalyapin EA; Bouley R; Hasler U; Vilardaga JP; Lin HY; Brown D; Ausiello DA
Kidney Int; 2008 Dec; 74(12):1557-67. PubMed ID: 18813286
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium.
Nickols HH; Shah VN; Chazin WJ; Limbird LE
J Biol Chem; 2004 Nov; 279(45):46969-80. PubMed ID: 15319442
[TBL] [Abstract][Full Text] [Related]
10. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
Juul KV; Bichet DG; Nielsen S; Nørgaard JP
Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration.
Bouley R; Lu HA; Nunes P; Da Silva N; McLaughlin M; Chen Y; Brown D
J Am Soc Nephrol; 2011 Jan; 22(1):59-72. PubMed ID: 21071524
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a functional V
Hus-Citharel A; Bouby N; Corbani M; Mion J; Mendre C; Darusi J; Tomboly C; Trueba M; Serradeil-Le Gal C; Llorens-Cortes C; Guillon G
Am J Physiol Renal Physiol; 2021 Sep; 321(3):F305-F321. PubMed ID: 34282956
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2.
Lu H; Sun TX; Bouley R; Blackburn K; McLaughlin M; Brown D
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F233-43. PubMed ID: 14519593
[TBL] [Abstract][Full Text] [Related]
14. Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.
Memetimin H; Izumi Y; Nakayama Y; Kohda Y; Inoue H; Nonoguchi H; Tomita K
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F620-8. PubMed ID: 19587140
[TBL] [Abstract][Full Text] [Related]
15. Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin.
Feinstein TN; Yui N; Webber MJ; Wehbi VL; Stevenson HP; King JD; Hallows KR; Brown D; Bouley R; Vilardaga JP
J Biol Chem; 2013 Sep; 288(39):27849-60. PubMed ID: 23935101
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2C is responsible for VP-induced dephosphorylation of AQP2 serine 261.
Cheung PW; Ueberdiek L; Day J; Bouley R; Brown D
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F404-F413. PubMed ID: 28381458
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin.
Sun TX; Van Hoek A; Huang Y; Bouley R; McLaughlin M; Brown D
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F998-1011. PubMed ID: 11997316
[TBL] [Abstract][Full Text] [Related]
18. Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney.
Fenton RA; Brønd L; Nielsen S; Praetorius J
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F748-60. PubMed ID: 17553938
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.
Robben JH; Knoers NV; Deen PM
Mol Biol Cell; 2004 Dec; 15(12):5693-9. PubMed ID: 15469988
[TBL] [Abstract][Full Text] [Related]
20. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists.
Robben JH; Kortenoeven ML; Sze M; Yae C; Milligan G; Oorschot VM; Klumperman J; Knoers NV; Deen PM
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12195-200. PubMed ID: 19587238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
